financetom
Business
financetom
/
Business
/
Chinese courier delivery firm BingEx files for US IPO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Chinese courier delivery firm BingEx files for US IPO
Sep 13, 2024 12:17 PM

Sept 13 (Reuters) - Chinese courier delivery firm

BingEx, which brands its services as 'FlashEx', has filed to go

public in the United States, a regulatory filing showed on

Friday.

WHY IT'S IMPORTANT

Several high-profile companies are trying to test investor

appetite for IPOs following a prolonged downturn due to rising

interest rates and geopolitical turmoil.

The number of Chinese companies that have pursued stock

market flotations in the United States has dropped in the past

few years, after ride-hailing giant Didi Global was forced to

delist its shares in late 2021 following a backlash from China's

regulators.

EV maker Zeekr's debut on the New York Stock Exchange

earlier this year was the first big listing by a Chinese company

in the U.S. since Didi's delisting.

CONTEXT

BingEx, citing data from iResearch, said it was the largest

independent on-demand dedicated courier service provider in

China according to revenue earned in 2023.

CICC, CLSA, Deutsche Bank and UBS Investment Bank are the

underwriters of the offering.

BY THE NUMBERS

BingEx's revenue rose to 4.53 billion Chinese yuan ($638.43

million) in 2023 compared with 4 billion Chinese yuan a year

earlier, the IPO prospectus showed.

It reported a profit of 110.5 million Chinese yuan in023

versus a loss of 180.4 million Chinese yuan a year earlier.

The company operates in 295 Chinese cities with 88.9 million

registered customers and had 2.7 million registered riders, as

of June 30.

It controlled 33.9% of the total independent on-demand

dedicated courier service market share in the country, as of

last year.

WHAT'S NEXT

BingEx, which did not reveal the terms of its offering, is

aiming to list American depositary shares (ADS) on the Nasdaq.

The company has applied to trade under the ticker symbol

"FLX".

($1 = 7.0955 Chinese yuan renminbi)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Factbox-Chinese EV makers set sights on European production
Factbox-Chinese EV makers set sights on European production
May 10, 2024
(Reuters) -Some Chinese carmakers are looking to set up manufacturing and assembly plants in Europe as they aim to ramp up sales of lower-cost cars in the region to rival their European competitors amid slowing demand at home. European imports of Chinese-made electric vehicles (EVs) have soared in recent years, raising concerns among domestic EV producers that they could suffer...
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
FDA Delays 'Important' Moderna Vaccine Review: William Blair Says 2025 Growth, '2026 Breakeven Story' Depends On It
May 10, 2024
The Food and Drug Administration (FDA) notified Moderna Inc ( MRNA ) on Friday that its review of a new vaccine has been delayed. The agency, citing administrative constraints, does not expect to complete its review of the Biologics License Application (BLA) for mRNA-1345, Moderna’s investigational respiratory syncytial virus (RSV) vaccine, by the Prescription Drug User Fee Act date of May 12, 2024. ...
Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise
Rocket Pharmaceuticals Says Blood Disorder Therapies Show Promise
May 10, 2024
09:28 AM EDT, 05/10/2024 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday that longer-term data on its experimental gene therapies to treat patients with rare blood disorders showed sustained safety and efficacy. Kresladi, a treatment for severe leukocyte adhesion deficiency, showed 100% stem cell transplantation-free survival with significant reductions in infection-related hospitalizations following engraftment, the company said. Data...
MediaAlpha Closes $144.2 Million Secondary Offering
MediaAlpha Closes $144.2 Million Secondary Offering
May 10, 2024
09:30 AM EDT, 05/10/2024 (MT Newswires) -- MediaAlpha ( MAX ) announced Friday the closing of a secondary offering of nearly 7.6 million class A common shares previously owned by affiliates of White Mountains Insurance Group ( WTM ) and Insignia Capital Group at $19 apiece, generating $144.2 million in gross proceeds for the selling shareholders. Underwriters for the deal...
Copyright 2023-2026 - www.financetom.com All Rights Reserved